WHO ICTRP trial
INM-755 cream for patients with EB.
EUCTR2021-000214-42-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2021-000214-42-DE |
|---|---|
| Public title | INM-755 cream for patients with EB. |
| Scientific title | A Randomised, Double-Blind, Vehicle-Controlled Phase 2 Study of Topically Applied INM-755 (cannabinol) Cream in Patients with Epidermolysis Bullosa. |
| Primary sponsor | InMed Pharmaceuticals Inc. |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Greece;Austria;Italy;Israel;Serbia;France;Germany;Spain |
| Conditions | Epidermolysis bullosa MedDRA version: 20.0 Level: PT Classification code 10014989 Term: Epidermolysis bullosa System Organ Class: 10010331 - Congenital, familial and genetic disorders ;Therapeutic area: Diseases [C] - Skin and Connective… |
| Interventions | Product Name: Cannabinol (CBN) Product Code: INM-755 Pharmaceutical Form: Cream INN or Proposed INN: CANNABINOL CAS Number: 521-35-7 Current Sponsor code: INM-755 Concentration unit: % percent Concentration type: equal Concentration number… |
| Registration date | Apr 19, 2021 |
| Target size | 20 |
| Secondary IDs | 755-201-EB |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: